Literature DB >> 2483165

Changes in pathways of pentose phosphate formation in relation to phosphoribosyl pyrophosphate synthesis in the developing rat kidney. Effects of glucose concentration and electron acceptors.

M Sochor1, S Kunjara, A L Greenbaum, P McLean.   

Abstract

Phosphoribosyl pyrophosphate (PPRibP), required in nucleotide synthesis, increases 2-fold in rat kidney from 1 day post partum to adult stage; there is no accompanying increase in PPRibP synthetase activity measured in vitro. Ribose 5-phosphate is a key factor in the regulation of PPRibP synthesis. The activity and regulation of 3 routes of ribose 5-phosphate formation have been measured in renal growth: (i) the flux through the oxidative pentose phosphate pathway was high in the neonatal period but increased only +50% thereafter; (ii) the non-oxidative pentose phosphate pathway, including transketolase, increased by +145%; (iii) the rate-limiting enzymes of the glucuronate-xylulose route increased +200% from 1 day to the adult stage. The importance of systems reoxidizing NADPH was shown by: (i) the stimulation of renal PPRibP formation from glucose by phenazine methosulphate; (ii) the early involvement of the oxidative pentose phosphate pathway at the stage where NADPH is used for biosynthetic routes; (iii) the increasing involvement of the glucuronate-xylulose route, which acts as a transhydrogenase producing NADP+ in addition to pentose phosphate formation and (iv) the correlation between renal PPRibP content and the activity of aldose reductase, which, by utilization of NADPH, stimulates ribose 5-phosphate formation via the oxidative pentose phosphate pathway. Evidence is adduced that the contribution of the 3 routes of ribose 5-phosphate formation in the kidney varies at different stages of development.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483165

Source DB:  PubMed          Journal:  J Dev Physiol        ISSN: 0141-9846


  4 in total

Review 1.  Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.

Authors:  Andras Perl; Robert Hanczko; Tiffany Telarico; Zachary Oaks; Steve Landas
Journal:  Trends Mol Med       Date:  2011-03-02       Impact factor: 11.951

2.  Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes.

Authors:  Sirilaksana Kunjara; A Leslie Greenbaum; Milena Sochor; Murad Ali; Allan Flyvbjerg; Henning Grønbaek; Patricia McLean
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

3.  Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.

Authors:  Robert Hanczko; David R Fernandez; Edward Doherty; Yueming Qian; Gyorgy Vas; Brian Niland; Tiffany Telarico; Adinoyi Garba; Sanjay Banerjee; Frank A Middleton; Donna Barrett; Maureen Barcza; Katalin Banki; Steve K Landas; Andras Perl
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

4.  Metabolomic analysis of differential changes in metabolites during ATP oscillations in chondrogenesis.

Authors:  Hyuck Joon Kwon; Yoshihiro Ohmiya
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.